Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial (vol 26, pg 5140, 2020) Ravindra Uppaluri , Katie M. Campbell , Ann Marie Egloff , Paul Zolkind , Zachary L. Skidmore , Brian Nussenbaum , Randal C. Paniello , Jason T. Rich , Ryan Jackson , Patrik Pipkorn , Loren S. Michel , Jessica Ley , Peter Oppelt , Gavin P. Dunn , Erica K. Barnell , Nicholas C. Spies , Tianxiang Lin , Tiantian Li , David T. Mulder , Youstina Hanna , Iulia Cirlan , Trevor J. Pugh , Tenny Mudianto , Rachel Riley , Liye Zhou , Vickie Y. Jo , Matthew D. Stachler , Glenn J. Hanna , Jason Kass , Robert Haddad , Jonathan D. Schoenfeld , Evisa Gjini , Ana Lako , Wade Thorstad , Hiram A. Gay , Mackenzie Daly , Scott J. Rodig , Ian S. Hagemann , Dorina Kallogjeri , Jay F. Piccirillo , Rebecca D. Chernock , Malachi Griffith , Obi L. Griffith , Douglas R. Adkins CLINICAL CANCER RESEARCH(2021)
AI 理解论文
溯源树
样例